Climate Health Medical

Hype and disputes surrounding blood pressure measurement

HQ Team October 17, 2024: Blood pressure measurement is a critical procedure in diagnosing and managing hypertension, yet it is fraught with scientific.

Read More
Climate Health Medical

Record decline in global carbon sinks in 2023; may upset climate models

HQ Team October 16, 2024: A new research  on the depleting carbon sinks on our planet has thrown up some crucial questions on.

Read More
Climate Health Pharma

European body to teach medical students health risks from climate change

Twenty-four European universities have formed a network to impart skills to 10,000 medical students across undergraduate degree programmes to address current and future.

Read More
Health Medical Opinion Pharma

Opinion: Casual mental health words spicing up normal chats not justifiable

By Aparna S October 16, 2024: Is it okay to use mental health words casually in everyday conversations? If you believe that this.

Read More
Drugs Health Medical

Understanding dementia: signs and care strategies for loved ones

Alvina Miller October 15, 2024: Finding out that you or someone close to you might have dementia can be really upsetting. But learning.

Read More
Drugs Health Medical

Breakthrough treatment may end insulin use in type 2 diabetic patients

HQ Team October 15, 2024: A recent study presented at the United European Gastroenterology Week congress in Vienna unveiled a procedure that could.

Read More
Drugs Health Medical

Danish study reveals half of patients with sepsis die within two years

HQ Team October 15, 2024: Severe sepsis and septic shock are major causes of mortality in intensive care unit (ICU) patients. According to.

Read More
Drugs Health Medical

New CAR T-cell therapy offers hope for children with aggressive blood cancer

HQ Team October 14, 2024: Children with aggressive blood cancer may soon have access to a new treatment, CAR T-cell therapy, targeting T-cell.

Read More
Drugs Health Pharma

Lundbeck targets epileptic drug, to buy Longboard for $2.6 billion

H. Lundbeck A/S, a Danish drugmaker, plans to acquire California, US-based Longboard Pharmaceuticals for $2.6 billion, giving it access to a late-stage drug.

Read More
Drugs Health Pharma

Pandemic threat looms, nations unprepared to handle crisis: WHO

Seventeen dangerous disease outbreaks, such as the Marburg virus and the latest strain of avian influenza this year, have increased the likelihood of.

Read More